How much CT do we need for PET/CT? A radiologist's perspective

NuklearMedizin

Volumn 44, Issue 5 A SUPPL. 1, 2005, Pages

  Kuehl, Hilmar ^a   Antoch, G ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

CT; PET CT

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE; IODINATED CONTRAST MEDIUM; METFORMIN; NONIONIC CONTRAST MEDIUM;

CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RADIATION DOSE; RADIODIAGNOSIS; REVIEW; THREE DIMENSIONAL IMAGING;

EID: 27644598268     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625211     Document Type: Review

References (45)

1. Antoch G, Saoudi N, Kuehl H et al. Accuracy of whole-body dual-modality fluorine-18-FDG PET and CT (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CT and PET. J Clin Oncol 2004; 22: 4357-68.
2. Wahl RL, Quint LE, Cieslak RD et al. "Anatometabolic" tumor imaging: Fusion of FDG PET with CT or MRI to licalize foci of increased activity. J Nucl Med 1993; 34: 1190-7.
3. Beyer T, Townsend DW, Brun T et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-79.
4. Antoch G, Freudenberg LS, Stattaus J et al. Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials. AJR Am J Roentgenol 2002; 179: 1555-60.
5. 18F-FDG PET/CT. J Nucl Med 2005; 46: 429-35.
6. ACR practice guideline for the performance of pediatric and adult thoracic CT. In: ACR practice guidelines & technical standards. ACR 2003: 143-7.
7. Schaefer-Prokop C, Prokop M. New imaging techniques in the treatment guidelines for lung cancer. Eur Respir J 2002; 19: Suppl 35, 71s-83s.
8. AWMF-Leitlinien Diagnostische Radiologie. AWMF-Leitlinien-Register 039/007 (www.uni-duesseldorf.de/WWW/AWMF/ll/039-007.htm).
9. Silvestri GA, Tanoue LT, Margolis ML et al. American College of Chest Physicians. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 2003; 123(1 Suppl): 147S-56S.
10. Fenchel S, Boll DT, Fleiter TR et al. Multislice helical CT of the pancreas and spleen. Eur J Radiol 2003; 45 Suppl 1: S59-72.
11. ACR practice guideline for the performance of CT of the abdomen and CT of the pelvis. In: ACR practice guidelines & technical standards. ACR 2002, 225-8. www.acr.org/s_acr/bin.asp?CID= 545&DID=12200.
12. Mortele KJ, Oliva MR, Ondategui S et al. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol 2005; 184: 31-4.
13. Rathsmann P, Jacobs GF, Muller RD. Intravenöse KM-Applikation bei älteren Patienten - Anwendungsbeobachtung von Iopentol (Imagopaque 300). RÖFO 2004; 176: 1826-31.
14. Jacobs JE, Birnbaum BA, Langlotz CP. Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology 1998; 209: 411-6.
15. Cochran ST, Bomyea K, Sayre JW. Trends in adverse events after IV administration of contrast media. AJR Am J Roentgenol 2001; 176: 1385-8.
16. 18F-FDG PET/CT. J Nucl Med 2004; 45 Suppl 1: 56S-65S.
17. Bepler G, Goodridge Carney D, Djulbegovic B et al. A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. Cancer Control 2003; 10: 306-14.
18. Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004; 231: 440-5.
19. Macari M, Bini EJ, Xue X et al. Colorectal neoplasms: prospective comparison of thin-section low-dose multi-detector row CT colonography and conventional colonoscopy for detection. Radiology 2002; 224: 383-92.
20. Cohnen M, Vogt C, Beck A et al. Feasibility of MDCT Colonography in ultra-low-dose technique in the detection of colorectal lesions: comparison with high-resolution video colonoscopy. AJR Am J Roentgenol 2004; 183: 1355-9.
21. Rajapaksa RC, Macari M, Bini EJ. Prevalence and impact of extracolonic findings in patients undergoing CT colonography. J Clin Gastroenterol 2004; 38: 767-71.
22. Knopfle E, Hamm M, Wartenberg S et al. CT in ureterolithiasis with a radiation dose equal to intravenous urography: results in 209 patients. RÖFO 2003; 175: 1667-72.
23. Tack D, Sourtzis S, Delpierre I, et al. Low-dose unenhanced multidetector CT of patients with suspected renal colic. AJR Am J Roentgenol 2003; 180: 305-11.
24. Yamada T, Ono S, Tsuboi M et al. Low-dose CT of the thorax in cancer follow-up. Eur J Radiol 2004; 51: 169-74.
25. Zhu X, Yu J, Huang Z. Low-dose chest CT: optimizing radiation protection for patients. AJR 2004; 183: 809-16.
26. Bockisch A, Beyer T, Antoch G et al. Principles of PET/CT and clinical application. Radiologe 2004; 44: 1045-54.
27. Feuerbach S, Lorenz W, Klose KJ et al. Contrast medium administraion in spiral CT: the results of a consensus conference. RÖFO 1996; 164: 158-65.
28. Yamashita Y, Komohara Y, Takahashi M et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material - a prospective randomised study. Radiology, 2000; 216: 718-23.
29. Nakamoto Y, Chin BB, Kraitchman DL et al. Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies. Radiology 2003; 227: 817-24.
30. Antoch G, Freudenberg LS, Egelhof T et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 2002; 43: 1339-42.
31. Yau YY, Chan WS, Tam YM et al. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? J Nucl Med 2005; 46: 283-91.
32. Berthelsen AK, Holm S, Loft A et al. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 2005; online DOI: 10.1007/s00259-005-1784-1.
33. Herman S. CT contrast enhancement principles and the use of high-concentration contrast material. J Comput Assist Tomogr 2004; 28 Suppl 1: S 7-11.
34. Awai K, Imuta M, Utsunomiya D et al. Contrast enhancement for whole-body screening using multidetector row helical CT: comparison between uniphasic and biphasic injection protocols. Radiat Med 2004; 22: 303-9.
35. Steinert HC. PET/CT bei Lymphompatienten. Radiologe 2004; 44: 1060-7.
36. Schaefer NG, Hany TF, Taverna C et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT? Radiology 2004; 232: 823-9.
37. Choi H. Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model. Curr Oncol Rep 2005; 7: 307-11.
38. Sandrasegaran K, Rajesh A, Rushing DA et al. Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 2005; 15: 1407-14.
39. Dizendorf E, Hany TF, Buck A et al. Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission data. J Nucl Med 2003; 44: 732-8.
40. Antoch G, Jentzen W, Freudenberg LS et al. Effect of ora contrast agents on CT-based PET attenuation correction in dual-modality PET/CT imaging. Invest Radiol 2003; 38: 784-9.
41. Otsuka H, Kubo A, Graham M et al. The relationship between standard uptake value (SUV) and Hounsfield Unit (HU) of oral contrast agent for FDG-PET/CT study. J Med Invest 2004; 51: 226-9.
42. Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med 2004; 45 Suppl 1: 82S-95S.
43. Groves AM, Kayani I, Dickson JC et al. Oral contrast medium in PET/CT: should you or shouldn't you? Eur J Nucl Med Mol Imaging 2005, online DOI: 10.1007/s00259-005-1833-9.
44. Antoch G, Kuehl H, Kanja J et al. Introduction and evaluation of a negative oral contrast agent to avoud contrast-induced artefacts in dual - modality PET/CT imaging. Radiology 2004; 230: 879-85.
45. Hausegger K, Reinprecht P, Kau T et al. Clinical experience with a commercially available negative oral contrast medium in PET/CT. RÖFO 2005; 177: 796-9.